An observational study in Erectile Dysfunction Following Urethral Surgery, sponsored by Kafrelsheikh University. Completed at 1 site in Egypt. Open to male participants. Per ClinicalTrials.gov, last updated 2025-01-28.
Sponsored by Kafrelsheikh University · Observational
to assess the effect of early tadalafil 5 mg once daily on persistent storage lower urinary tract symptoms (LUTS) and erectile function after transurethral resection of the prostate (TURP).
683 studies on the registry are indexed under Erectile Dysfunction; 117 are open to participants now.
This study's enrollment of 270 is above the median of 130 across 115 observational studies indexed under Erectile Dysfunction.
Browse Erectile Dysfunction studies →Kafrelsheikh University is the lead sponsor of 285 studies on the registry; 110 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Sexual active male patients underwent TURP
Exclusion Criteria:
Drug: Tadalafil 5mg
Drug: Placebo
Patient recive tadalafil 5mg once daily early post turp
Patient recive placebo once daily early post turp
Assess erectile function
Using IIEF score
Time frame: One month
Assess erectile function
Usine IIEF score
Time frame: 3 month
Assess storage symptoms
Using IPSS Score
Time frame: One month
Assess storage symptoms
Using IPSS score
Time frame: 3 month
This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kafrelsheikh University